Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

Phase 4

Completed

• Conditions: Rhinitis Allergic; Asthma

• Registration Number: NCT00380705
• Lead Sponsor: Organon and Co

Brief Summary

Allow physicians not familiar with anti-leukotriene based therapy to test it

Detailed Description

Not available

Study Timeline

• Study Start: 2005-03-18
• Primary Completion: 2005-07-29
• Study Completion: 2005-07-29
• Study First Submitted: 2006-09-22
• Study First Submitted QC: 2006-09-22
• Study First Posted: 2006-09-26
• Status Verified: 2022-01
• Last Update Submitted: 2024-08-12
• Last Update Posted: 2024-08-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 91

Inclusion Criteria

• Establish diagnosis of mild to moderate chronic asthma and/or allergic rhinitis currently on treatment
• Voluntary acceptance to participate in the study

Exclusion Criteria

• Patients with cystic fibrosis
• Patients with known hypersensitivity to singulair or any of its components
• Patients with severe chronic asthma

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Quality of life measures

Secondary Outcome Measures

Name	Time	Method
Nocturnal wake up, work or school absences, physical activity and recurrence of asthma and/or rhinitis